ArticleFrontiers in endocrinology2026
An interpretable nomogram for predicting early acute postoperative hypocalcemia in differentiated thyroid cancer: development and internal validation.
Article in Frontiers in endocrinology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Postoperative hypocalcemia (HC) is a frequent complication following thyroidectomy. Balancing prophylactic calcium supplementation against avoiding overtreatment remains a clinical dilemma. This study aimed to develop and independently validate an interpretable machine learning (ML) model to predict early acute postoperative HC in patients with differentiated thyroid cancer (DTC). Methods: In accordance with the Transparent Reporting of a multivariable prediction model for Individual Prognosis or Diagnosis plus Artificial Intelligence reporting guideline, diverse clinical, biochemical, and surgical parameters from 876 DTC patients (February 2023-January 2026) were retrospectively analyzed. Early acute postoperative HC was defined as biochemical or symptomatic hypocalcemia occurring within the first 24 hours after surgery. The cohort was randomly split into a training set (80%, n = 701) and an independent holdout test set (20%, n = 175). Seven ML algorithms were trained and evaluated. Shapley Additive exPlanations (SHAP) and a clinical nomogram were utilized for model interpretation and clinical application. Results: The overall incidence of early acute postoperative HC was 38.2% (335/876). While complex ensemble models showed comparable performance, Logistic Regression (LR) was selected as the final model for its optimal balance of favorable discrimination (area under the receiver operating characteristic curve in the test set = 0.760) and clinical transparency. Multivariate and SHAP analyses revealed that preoperative serum magnesium, body mass index, lateral cervical lymph node dissection, and explicit parathyroid autotransplantation dynamics (specifically implantation into the neck muscle, odds ratio = 6.808) were critical drivers of HC. The LR-derived nomogram demonstrated excellent sensitivity (0.806 in the test set) at the optimal threshold of 0.372. Decision curve analysis confirmed superior net clinical benefit across relevant threshold probabilities, and subgroup analyses verified the model's stability across age and sex strata. Conclusions: We developed and independently validated a transparent, highly discriminative LR-based nomogram for predicting early acute postoperative HC within the first 24 hours after thyroidectomy. Integrating precise surgical factors and biochemical profiles, this tool facilitates individualized perioperative monitoring and tailored calcium supplementation strategies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.